Stroke
Expression of Concern for: "Nasal Administration of Recombinant Osteopontin Attenuates Early Brain Injury After Subarachnoid Hemorrhage".
Published: 202510.1161/STR.0000000000000496
No abstract available for this study.
No abstract available for this study.